Today's Date: February 21, 2024
Sallie Mae CFO to Speak at 2024 RBC Capital Markets Global Financial Institutions Conference   •   Green Plains to Participate in Bank of America 2024 Global Agriculture and Materials Conference   •   Black Health Matters Winter Health Summit and Expo Returns to Atlanta   •   PG&E Identifies More than 20 Climate-Tech Solutions Aimed at Achieving a Clean Energy Future   •   A City Boy Discovers Nature's Playground: New Book Inspires Children to Connect with the Great Outdoors   •   Lake Babine Nation and Canada sign agreement to support community vision for governance, capacity development, and infrastructur   •   Independent Women's Voice Testifies Before Alabama Legislature in Support of HB 111 & SB 92 to Establish Legal Definitions o   •   Perdoceo Education Corporation Reports Fourth Quarter and Full Year 2023 Results   •   Orbia Announces Fourth Quarter and Full-Year 2023 Financial Results   •   Semrush Holdings, Inc. to Participate in Upcoming Investor Conferences   •   Californians for Financial Education Campaign Applauds New Legislation Requiring Personal Finance Education for All Students   •   Energy Recovery Announces CFO Transition   •   Ziegler Prices Financing For The United Methodist Retirement Homes   •   Government of Canada and Mushkegowuk Council successfully complete feasibility assessment and take a major step toward officiall   •   Helping Canadian creative businesses and organizations achieve financial success on the world stage   •   Annual Arts in Hong Kong Event to Kick-off in March Offering a Variety of Arts Experiences Along Iconic Victoria Harbour   •   National Geographic Documentary Films Acquires Sundance Film Festival Award-Winner SUGARCANE   •   Avangrid Fourth Quarter & Full Year 2023 Financial Results Available on Company’s Website   •   Why is skin disease often misdiagnosed and untreated in Black patients?   •   Pinterest to Participate at the Morgan Stanley Technology, Media & Telecom Conference
Bookmark and Share

Breast Cancer Canada Grants $2.5 Million to McPeak-Sirois Group to Expand Access to Clinical Research

TORONTO , December 11 /Businesswire/ - Today, Breast Cancer Canada, a national charity dedicated to saving lives through breast cancer research, announced a new and innovative partnership with McPeak-Sirois Group for Clinical Research in Breast Cancer, one of the largest breast cancer clinical research consortiums in Canada, to expand access to clinical research in breast cancer throughout Quebec. This funding marks Breast Cancer Canada’s first major investment in Quebec research.

This press release features multimedia. View the full release here:

Kimberly Carson, CEO of Breast Cancer Canada, and Susan McPeak, co-founder of the McPeak-Sirois Group for Clinical Research in Breast Cancer, announcing the partnership at the San Antonio Breast Cancer Symposium. (Photo: Business Wire)

Kimberly Carson, CEO of Breast Cancer Canada, and Susan McPeak, co-founder of the McPeak-Sirois Group for Clinical Research in Breast Cancer, announcing the partnership at the San Antonio Breast Cancer Symposium. (Photo: Business Wire)

The $2.5 million commitment to McPeak-Sirois Group will be granted over the next five years and will support the Programme Accès-recherche Dr. André-Robidoux aiming at making clinical research more accessible to patients living outside major urban areas. The funding will amplify the geographical reach and impact of the Group while enabling regional hospitals to offer more clinical trials for the benefit of their patients.

“We would like to thank Breast Cancer Canada for this partnership which represents a major milestone for our Group. Breast Cancer Canada’s funding will allow for growth in the number of Quebec hospitals offering breast cancer clinical trials and improve access to innovative treatments to patients,” shared Dominique Johnson, Managing Director of the Group. “Our objective is to double our reach from 10 to more than 20 hospitals. This funding infusion is empowering us to reach a broader patient base and bring clinical research closer to patients.”

"We are extremely proud to partner with McPeak-Sirois Group," said Kimberly Carson, CEO of Breast Cancer Canada. "Together, we are amplifying access to clinical trials and reaching more Canadian breast cancer patients. This partnership represents a significant step forward in our ongoing mission to improve outcomes and transform the breast cancer landscape to be personalized to each individual."

The partnership between Breast Cancer Canada and McPeak-Sirois Group brings together the expertise and resources of two esteemed Canadian not-for-profit organizations. By leveraging their combined strengths, the aim is to drive tangible progress to increase access to state-of-the-art treatments for patients living in all regions of Quebec. Since the beginning of this partnership, the CISSS de Lanaudière has joined the Consortium as its 11th member.

Susan McPeak, co-founder of the McPeak-Sirois Group, comments: “This funding will catalyze substantial growth for our consortium, enabling the expansion of clinical trial offerings across the province of Quebec. As a former patient and clinical trial participant myself, I know how important it is to be given access to research that cares, regardless of where you live.”

Earlier this year Breast Cancer Canada launched PROgress Tracker. McPeak-Sirois Group was an early advocate for the release of the national, first-of-its-kind knowledge registry that will collect experiences over the next 10 years from people with breast cancer. The intention is to use the data to inform policy and future breast cancer management. BCC is now accepting participants who have or have had any stage of breast cancer, at any time during their journey, to register in PROgress Tracker available in both French and English.

About Breast Cancer Canada:

Breast Cancer Canada (formerly the Breast Cancer Society of Canada) is a national charity dedicated to saving lives through breast cancer research. With a focus on precision oncology (personalized care), it is the only national breast cancer organization in Canada that has a clear mandate to raise money for research. The organization receives no government funding, meaning all research is funded through the generosity of donors. For more information visit,

About The McPeak-Sirois Group:

The McPeak-Sirois Group is a charitable organization whose mission is to fight breast cancer more effectively by increasing patients’ access and participation in clinical trials. The Group’s scientific committee is made up of internationally renowned scientists who oversee the selection of clinical studies offered to the consortium’s member hospitals. Co-founded in 2015 by Susan McPeak, a breast cancer survivor, and Charles Sirois, a well-known entrepreneur, the McPeak-Sirois Group is committed to promoting research that cares by bringing it closer to breast cancer patients throughout Quebec.

STORY TAGS: Photo/Multimedia, Other Health, General Health, Pharmaceutical, Philanthropy, Oncology, Consumer, Fund Raising, Foundation, Clinical Trials, Women, Other Philanthropy, Health, Funding, Nonprofit, North America, Canada, Quebec, Ontario,


White House Live Stream
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News